Combining sodium-glucose co-transporter-2 inhibitor with mesenchymal stem cells and brown adipose tissue (BAT) and white adipose tissue (WAT) transplantation to mitigate the progression of diabetic kidney disease: a pre-clinical approach
2025 · Stem Cell Research & Therapy · 1 citations
https://doi.org/10.1186/s13287-025-04358-7